Connect with us

Life Sciences

Highlights from the journal CHEST®, September 2023

Glenview, Illinois – Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical…

Published

on

This article was originally published by BioEngineering

Glenview, Illinois – Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

How Do Oronasal Masks Affect Upper Airway Anatomy and Collapsibility?

Credit: Landry SA, et al. CHEST September 2023

Glenview, Illinois – Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The September issue of the CHEST journal contains 42 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia resources, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“What is known about long COVID is continually evolving, and the September issue includes a CHEST Review on the latest research,” says Editor in Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “’Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2’ illustrates exercise pathophysiologic commonalities between these syndromes that will help guide future diagnostics and treatment.”

Additional highlights from the latest issue of the journal CHEST include:

  • Asthma
    Original asthma research, Albuterol-Budesonide Pressurized Metered Dose Inhaler in Patients With Mild-to-Moderate Asthma, confirms the contribution of both monocomponents to the lung function efficacy of the albuterol-budesonide combination pressurized metered-dose inhaler. View the visual abstract for this research.

  • Chest Infections
    A multicenter observational cohort study, Procalcitonin-Guided Antibiotic Prescription in Patients With COVID-19 , finds that procalcitonin-guided antibiotic prescription reduces antibiotic prescription rates in hospitalized patients with COVID-19 without major safety concerns. Listen to a podcast on the research, and view the accompanying visual abstract for this research.

  • Sleep
    Original research, Oronasal vs Nasal Masks: The Impact of Mask Type on CPAP Requirement, Pharyngeal Critical Closing Pressure (Pcrit), and Upper Airway Cross-Sectional Areas in Patients With OSA, studies how oronasal masks affect upper airway anatomy and collapsibility. View the visual abstract for this research.

  • Thoracic Oncology
    Trends in Smoking-Specific Lung Cancer Incidence Rates Within a US Integrated Health System, 2007-2018 underscores the need to elucidate further the cause of lung cancer in adults who have never used tobacco, including why incidence is higher and rising in Asian and Pacific Islander adults who have never used tobacco. View the visual abstract for this research.

To view the entire September issue of the CHEST journal, visit journal.chestnet.org, and follow @journal_CHEST on social media for the latest journal news.

About the American College of Chest Physicians

The American College of Chest Physicians® (CHEST) is the global leader in the prevention, diagnosis and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 22,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST®, visit chestnet.org.







Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending